Company intelligence / Profile preview

Osmetech

Pasadena, California, USA

Ownership: Private
Development stage: Other

Overview

Osmetech was a molecular diagnostics company that developed and commercialized the eSensor technology platform for DNA and RNA detection. The company's flagship product, the eSensor XT-8 system, provided automated, multiplexed testing for clinical applications such as pharmacogenetics and infectious diseases. Osmetech's technology utilized electrochemical detection, offering a robust alternative to traditional optical methods for genetic analysis. In 2010, the company underwent a significant corporate restructuring and was renamed GenMark Diagnostics, which was subsequently acquired by Roche in 2021.

Therapeutic areas: HematologyCardiovascularPulmonologyInfectious Diseases
Modalities: Device
Industry: Molecular Diagnostics

Partnerships

Motorola

Beyond the preview

Go deeper on Osmetech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osmetech.

Explore the full profile